ArticleMembranes2023
Development of a Green Polymeric Membrane for Sodium Diclofenac Removal from Aqueous Solutions.
Article in Membranes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 12 citations in OpenAlex.
- Tri-Layer Composite Nanofiber Wound Dressing Incorporating Glucantime and Silver Nanoparticles for Cutaneous Leishmaniasis Management.Journal of functional biomaterials · 2026Article
- Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
Water-soluble polymers provide an alternative to organic solvent requirements in membrane manufacture, aiming at accomplishing the Green Chemistry principles. Poly(vinyl alcohol) (PVA) is a biodegradable and non-toxic polymer renowned for its solubility in water. However, PVA is little explored in membrane processes due to its hydrophilicity, which reduces its stability and performance. Crosslinking procedures through an esterification reaction with carboxylic acids can address this concern. For this, experimental design methodology and statistical analysis were employed to achieve the optimal crosslinking conditions of PVA with citric acid as a crosslinker, aiming at the best permeate production and sodium diclofenac (DCF) removal from water. The membranes were produced following an experimental design and characterized using multiple techniques to understand the effect of crosslinking on the membrane performance. Characterization and filtration results demonstrated that crosslinking regulates the membranes' properties, and the optimized conditions (crosslinking at 110 °C for 110 min) produced a membrane able to remove 44% DCF from water with a permeate production of 2.2 L m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.